Your browser doesn't support javascript.
loading
Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we? - results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United Kingdom.
Joshi, Hrishi; Sali, Gaurav; Paramore, Louise; Jones, Richard; Lazarowicz, Henry; Kujawa, Magda Lucia; Pandit, Amol; David, Rotimi; Wilson, Katherine; Bates, Christopher; Shergill, I; Gan, Christine; El-Husseiny, Tamer; Mukhtar, Bashir; Appanna, Timson; Veeratterapillay, Rajan; Harding, Christopher; Crockett, Matthew; Dawson, Christopher; Simpson, Richard; Zelhof, Bachar; Starmer, B; Mukherjee, Rono; Bourdoumis, Andreas; Jelski, Joseph; Hashim, H; McCabe, John; Shaw, Greg; Chow, Karyee; Betts, Christopher.
Afiliación
  • Joshi H; Consultant Urological Surgeon and Honorary lecturer, Department of Urology, University Hospital of Wales, UK.
  • Sali G; Clinical Fellow in Urology, Department of Urology, University Hospital of Wales, UK.
  • Paramore L; Specialist Registrar in Urology, Department of Urology, University Hospital of Wales, UK.
  • Jones R; Specialist Registrar in Urology, Department of Urology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK.
  • Lazarowicz H; Consultant Urological Surgeon, Department of Urology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK.
  • Kujawa ML; Consultant Urological Surgeon, Department of Urology, Stepping Hill Hospital, UK.
  • Pandit A; Consultant Urological Surgeon, Department of Urology, Morriston Hospital, UK.
  • David R; Clinical Fellow in Urology , Department of Urology, Morriston Hospital, UK.
  • Wilson K; Specialist Registrar in Urology, Department of Urology, Royal Gwent Hospital, UK.
  • Bates C; Consultant Urological Surgeon, Department of Urology, Royal Gwent Hospital, UK.
  • Shergill I; Consultant Urological Surgeon, Department of Urology, Wrexham Maelor Hospital, UK.
  • Gan C; Consultant Urological Surgeon, Department of Urology, Charing Cross Hospital - Imperial College Healthcare NHS Trust, UK.
  • El-Husseiny T; Consultant Urological Surgeon, Department of Urology, Charing Cross Hospital - Imperial College Healthcare NHS Trust, UK.
  • Mukhtar B; Specialist Registrar in Urology, Department of Urology, Cwm Taf Morgannwg Health Board Royal Glamorgan Hospital, UK.
  • Appanna T; Consultant Urological Surgeon, Department of Urology, Cwm Taf Morgannwg Health Board Royal Glamorgan Hospital, UK.
  • Veeratterapillay R; Consultant Urological Surgeon, Department of Urology, Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK.
  • Harding C; Consultant Urological Surgeon, Department of Urology, Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK.
  • Crockett M; Specialist Registrar in Urology, Department of Urology, Gloucestershire Hospitals NHS Foundation Trust, UK.
  • Dawson C; Consultant Urological Surgeon, Department of Urology, University Hospitals Birmingham NHS Foundation Trust, UK.
  • Simpson R; Specialist Registrar in Urology, Department of Urology, Lancashire Teaching Hospitals NHS Foundation Trust, UK.
  • Zelhof B; Consultant Urological Surgeon, Department of Urology, Lancashire Teaching Hospitals NHS Foundation Trust, UK.
  • Starmer B; Consultant Urological Surgeon, Department of Urology, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, UK.
  • Mukherjee R; Consultant Urological Surgeon, Department of Urology, Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust, UK.
  • Bourdoumis A; Consultant Urological Surgeon, Department of Urology, Penine Acute Hospitals NHS Trust, The Royal Oldham Hospital, UK.
  • Jelski J; Specialist Registrar, Department of Urology, Southmead Hospital, North Bristol NHS Trust, UK.
  • Hashim H; Specialist Registrar, Department of Urology, Southmead Hospital, North Bristol NHS Trust, UK.
  • McCabe J; Consultant Urological Surgeon, Department of Urology, St Helens and Knowsley Teaching Hospitals NHS Trust, UK.
  • Shaw G; Consultant Urological Surgeon, Department of Urology, University College London Hospitals NHS Foundation Trust, UK.
  • Chow K; Consultant Urological Surgeon, Department of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, UK.
  • Betts C; Consultant Urological Surgeon, Department of Urology, Salford Royal NHS Foundation Trust, UK.
Scott Med J ; 66(2): 58-65, 2021 May.
Article en En | MEDLINE | ID: mdl-33459189
OBJECTIVE: In view of changing landscape of surgical treatment for LUTS secondary to BPE, this audit was undertaken to assess key aspects of the processes and outcomes of the current interventional treatments for BPE, across different units in the UK. MATERIALS AND METHOD: A multi-institutional snapshot audit was conducted for patients undergoing interventions for LUTS/BPE over 8-week period. Using Delphi process two-part proforma was designed to capture data. RESULTS: 529 patients were included across 20 NHS trusts in England and Wales. Median age was 73 years. Indications for surgery were acute retention (47%) and LUTS (45%). 80% of patients had prior medical therapy. TURP formed the commonest procedure. 27% patients had <23 hour hospital stay. Immediate (21%) and delayed (18%) complications were Clavien-Dindo <2 category. High proportion of patients reported residual symptoms. Type and indication of surgery were significant predictor of complications, length of stay and failure of TWOC outcomes, on multivariate analyses. There were variations in departmental processes, 50% centres used PROMs. CONCLUSION: Monopolar TURP still remains the commonest intervention for BPE. Most departments are adopting newer technologies. The audit identified opportunities for development of consistent, effective and patient centric practices as well as need for large-scale focused studies.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Resección Transuretral de la Próstata / Síntomas del Sistema Urinario Inferior Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Prognostic_studies Aspecto: Patient_preference Límite: Aged / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Scott Med J Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Resección Transuretral de la Próstata / Síntomas del Sistema Urinario Inferior Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Prognostic_studies Aspecto: Patient_preference Límite: Aged / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Scott Med J Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido